It is of note that LCAD and VLCAD metabolize long-chain fatty acids in the mice, whereas VLCAD is the active enzyme in humans, so that there are only patients affected by deficient activity of VLCAD. The gene discussed is ACADVL; the disease is very long chain acyl-CoA dehydrogenase deficiency.